These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 25159060)

  • 1. Process modeling and optimization of a cell therapy manufacturing operation.
    Chisholm ME; Hopkins DJ
    Regen Med; 2014; 9(4):427-30. PubMed ID: 25159060
    [No Abstract]   [Full Text] [Related]  

  • 2. A tool for modeling strategic decisions in cell culture manufacturing.
    Farid SS; Novais JL; Karri S; Washbrook J; Titchener-Hooker NJ
    Biotechnol Prog; 2000; 16(5):829-36. PubMed ID: 11027178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modelling approaches for bio-manufacturing operations.
    Chhatre S
    Adv Biochem Eng Biotechnol; 2013; 132():85-107. PubMed ID: 23183689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The translation of cell-based therapies: clinical landscape and manufacturing challenges.
    Heathman TR; Nienow AW; McCall MJ; Coopman K; Kara B; Hewitt CJ
    Regen Med; 2015; 10(1):49-64. PubMed ID: 25562352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modeling using discrete event simulation: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force--4.
    Karnon J; Stahl J; Brennan A; Caro JJ; Mar J; Möller J;
    Value Health; 2012; 15(6):821-7. PubMed ID: 22999131
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expansion processes for cell-based therapies.
    Scibona E; Morbidelli M
    Biotechnol Adv; 2019 Dec; 37(8):107455. PubMed ID: 31629791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cellular manufacturing for clinical applications.
    Sheu J; Klassen H; Bauer G
    Dev Ophthalmol; 2014; 53():178-88. PubMed ID: 24732771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dendritic cells: active and passive players in therapy of human diseases.
    Tabarkiewicz J
    Immunotherapy; 2012 Oct; 4(10):975-8. PubMed ID: 23148747
    [No Abstract]   [Full Text] [Related]  

  • 9. A new large-scale manufacturing platform for complex biopharmaceuticals.
    Vogel JH; Nguyen H; Giovannini R; Ignowski J; Garger S; Salgotra A; Tom J
    Biotechnol Bioeng; 2012 Dec; 109(12):3049-58. PubMed ID: 22688835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The ATMP Manufacturing Community (amc).
    Foley L; Callens S; Osborne A
    Regen Med; 2012 May; 7(3):285-9. PubMed ID: 22594322
    [No Abstract]   [Full Text] [Related]  

  • 11. Enabling advanced cell therapies (EnACT): invitation to an online forum on resolving barriers to clinical translation.
    Bubela T; Reshef A; Li MD; Atkins H; Caulfield T; Culme-Seymour E; Gold ER; Illes J; Isasi R; McCabe C; Ogbogu U; Piret J; Mason C
    Regen Med; 2012 Nov; 7(6):735-40. PubMed ID: 23020169
    [No Abstract]   [Full Text] [Related]  

  • 12. Deciphering the therapeutic stem cell strategies of large and midsize pharmaceutical firms.
    Vertès AA
    Regen Med; 2014; 9(4):479-95. PubMed ID: 25159065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A kinetic modeling of chondrocyte culture for manufacture of tissue-engineered cartilage.
    Kino-Oka M; Maeda Y; Yamamoto T; Sugawara K; Taya M
    J Biosci Bioeng; 2005 Mar; 99(3):197-207. PubMed ID: 16233778
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mammalian cell cultures for biologics manufacturing.
    Kantardjieff A; Zhou W
    Adv Biochem Eng Biotechnol; 2014; 139():1-9. PubMed ID: 24258145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An engineering study on the enhanced control and operation of continuous manufacturing of pharmaceutical tablets via roller compaction.
    Singh R; Ierapetritou M; Ramachandran R
    Int J Pharm; 2012 Nov; 438(1-2):307-26. PubMed ID: 22982489
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Review of modeling approaches for emergency department patient flow and crowding research.
    Wiler JL; Griffey RT; Olsen T
    Acad Emerg Med; 2011 Dec; 18(12):1371-9. PubMed ID: 22168201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modeling of cell culture damage and recovery leads to increased antibody and biomass productivity in CHO cell cultures.
    Naderi S; Nikdel A; Meshram M; McConkey B; Ingalls B; Budman H; Scharer J
    Biotechnol J; 2014 Sep; 9(9):1152-63. PubMed ID: 24852214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Capacity optimization and scheduling of a multiproduct manufacturing facility for biotech products.
    Shaik MA; Dhakre A; Rathore AS; Patil N
    Biotechnol Prog; 2014; 30(5):1221-30. PubMed ID: 25079608
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Innovation leading the way: application of lean manufacturing to sample management.
    Allen M; Wigglesworth MJ
    J Biomol Screen; 2009 Jun; 14(5):515-22. PubMed ID: 19483142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hybrid and disposable facilities for manufacturing of biopharmaceuticals: pros and cons.
    Ravisé A; Cameau E; De Abreu G; Pralong A
    Adv Biochem Eng Biotechnol; 2009; 115():185-219. PubMed ID: 19623478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.